Table 1 Recent WHO recommendation for “low dose” primaquine as a P. falciparum gametocytocide[51]

In: (1) areas threatened by artemisinin resistance where single dose primaquine as a gametocytocide for P. falciparum malaria is not being implemented, and (2) elimination areas which have not yet adopted primaquine as a gametocytocide for P. falciparum malaria:

A single 0.25 mg base/kg primaquine dose should be given to all patients with parasitologically- confirmed P. falciparum malaria on the first day of treatment in addition to an ACT, except for pregnant women and infants <1 year of age.